Healthcare M&A activity is expected to heat up in 2025, with deal volumes and values showing potential signs of acceleration. However, this optimism could be tempered by uncertainties stemming from tariffs and the broader macroeconomic environment. The imposition of new tariffs has introduced significant unpredictability, which could lead to more cautious deal-making in the short term.